Clinical Trial

Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal

Study acronym: STEREO-HBM
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This prospective 2-stage, non-randomized Phase 2 trial evaluates the safety and efficacy of FSRT for the management of hemorrhagic brain metastases
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-10-04; most recent amendment 2025-02-07.
Status change: Not Yet Recruiting → Recruiting 2019-05-21
Trial Details
NCT Number NCT03696680
Lead Sponsor Centre Francois Baclesse
Collaborators: ANOCEF/IGCNO, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions Hemorrhagic Brain Metastases
Enrollment 46 participants
Start Date 2019-01-16
Primary Completion 2027-06 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11